BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

564 related articles for article (PubMed ID: 29263159)

  • 1. Pathogenicity of a Human Laminin
    Funk SD; Bayer RH; Malone AF; McKee KK; Yurchenco PD; Miner JH
    J Am Soc Nephrol; 2018 Mar; 29(3):949-960. PubMed ID: 29263159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alport syndrome and Pierson syndrome: Diseases of the glomerular basement membrane.
    Funk SD; Lin MH; Miner JH
    Matrix Biol; 2018 Oct; 71-72():250-261. PubMed ID: 29673759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Laminin β2 gene missense mutation produces endoplasmic reticulum stress in podocytes.
    Chen YM; Zhou Y; Go G; Marmerstein JT; Kikkawa Y; Miner JH
    J Am Soc Nephrol; 2013 Jul; 24(8):1223-33. PubMed ID: 23723427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Laminin-521 Protein Therapy for Glomerular Basement Membrane and Podocyte Abnormalities in a Model of Pierson Syndrome.
    Lin MH; Miller JB; Kikkawa Y; Suleiman HY; Tryggvason K; Hodges BL; Miner JH
    J Am Soc Nephrol; 2018 May; 29(5):1426-1436. PubMed ID: 29472414
    [No Abstract]   [Full Text] [Related]  

  • 5. A deletion in the N-terminal polymerizing domain of laminin β2 is a new mouse model of chronic nephrotic syndrome.
    Funk SD; Bayer RH; McKee KK; Okada K; Nishimune H; Yurchenco PD; Miner JH
    Kidney Int; 2020 Jul; 98(1):133-146. PubMed ID: 32456966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A missense LAMB2 mutation causes congenital nephrotic syndrome by impairing laminin secretion.
    Chen YM; Kikkawa Y; Miner JH
    J Am Soc Nephrol; 2011 May; 22(5):849-58. PubMed ID: 21511833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The glomerular basement membrane as a barrier to albumin.
    Suh JH; Miner JH
    Nat Rev Nephrol; 2013 Aug; 9(8):470-7. PubMed ID: 23774818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Forced expression of laminin beta1 in podocytes prevents nephrotic syndrome in mice lacking laminin beta2, a model for Pierson syndrome.
    Suh JH; Jarad G; VanDeVoorde RG; Miner JH
    Proc Natl Acad Sci U S A; 2011 Sep; 108(37):15348-53. PubMed ID: 21876163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LAMB2 mutation with different phenotypes in China
.
    Zhang H; Cui J; Wang F; Xiao H; Ding J; Yao Y
    Clin Nephrol; 2017 Jan; 87 (2017)(1):33-38. PubMed ID: 27925579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelial cell-specific collagen type IV-α
    Funk SD; Bayer RH; Miner JH
    Am J Physiol Renal Physiol; 2019 May; 316(5):F830-F837. PubMed ID: 30724107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First Japanese case of Pierson syndrome with mutations in LAMB2.
    Togawa H; Nakanishi K; Mukaiyama H; Hama T; Shima Y; Nakano M; Fujita N; Iijima K; Yoshikawa N
    Pediatr Int; 2013 Apr; 55(2):229-31. PubMed ID: 23679161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A mouse Col4a4 mutation causing Alport glomerulosclerosis with abnormal collagen α3α4α5(IV) trimers.
    Korstanje R; Caputo CR; Doty RA; Cook SA; Bronson RT; Davisson MT; Miner JH
    Kidney Int; 2014 Jun; 85(6):1461-8. PubMed ID: 24522496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of the ocular features in Pierson and Alport syndrome: a case report and literature review.
    Gooley K; Williams P; Mack H; Zhu V; Langsford D; Pianta T; Barit D; Mahmood K; Savige J
    Ophthalmic Genet; 2023 Oct; 44(5):417-422. PubMed ID: 37537573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Next-generation sequencing to dissect hereditary nephrotic syndrome in mice identifies a hypomorphic mutation in Lamb2 and models Pierson's syndrome.
    Bull KR; Mason T; Rimmer AJ; Crockford TL; Silver KL; Bouriez-Jones T; Hough TA; Chaudhry S; Roberts IS; Goodnow CC; Cornall RJ
    J Pathol; 2014 May; 233(1):18-26. PubMed ID: 24293254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic, Clinical, and Pathologic Backgrounds of Patients with Autosomal Dominant Alport Syndrome.
    Kamiyoshi N; Nozu K; Fu XJ; Morisada N; Nozu Y; Ye MJ; Imafuku A; Miura K; Yamamura T; Minamikawa S; Shono A; Ninchoji T; Morioka I; Nakanishi K; Yoshikawa N; Kaito H; Iijima K
    Clin J Am Soc Nephrol; 2016 Aug; 11(8):1441-1449. PubMed ID: 27281700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laminin compensation in collagen alpha3(IV) knockout (Alport) glomeruli contributes to permeability defects.
    Abrahamson DR; Isom K; Roach E; Stroganova L; Zelenchuk A; Miner JH; St John PL
    J Am Soc Nephrol; 2007 Sep; 18(9):2465-72. PubMed ID: 17699809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A COL4A4-G394S Variant and Impaired Collagen IV Trimerization in a Patient with Mild Alport Syndrome.
    Kohler J; Omachi K; Charu V; Miner JH; Bhalla V
    Kidney360; 2022 Nov; 3(11):1899-1908. PubMed ID: 36514391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skeletal impairment in Pierson syndrome: Is there a role for lamininβ2 in bone physiology?
    Beaufils C; Farlay D; Machuca-Gayet I; Fassier A; Zenker M; Freychet C; Bonnelye E; Bertholet-Thomas A; Ranchin B; Bacchetta J
    Bone; 2018 Jan; 106():187-193. PubMed ID: 29051055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel LAMB2 gene mutation associated with a severe phenotype in a neonate with Pierson syndrome.
    Zemrani B; Cachat F; Bonny O; Giannoni E; Durig J; Fellmann F; Chehade H
    Eur J Med Res; 2016 Apr; 21():19. PubMed ID: 27130041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel mutation of laminin β2 (LAMB2) in two siblings with renal failure.
    Falix FA; Bennebroek CA; van der Zwaag B; Lapid-Gortzak R; Florquin S; Oosterveld MJ
    Eur J Pediatr; 2017 Apr; 176(4):515-519. PubMed ID: 28188379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.